A team of students from the University of the Philippines and Ateneo de Manila University won in GlaxoSmithKline (GSK)’s Enterprise, the annual corporate strategy competition that gives top college students the chance to take on executive team posts and showcase their analytical skills in a round of competitions leading to a final boardroom presentation to GSK executives.
“Enterprise is all about giving students the opportunity to explore the landscape of the corporate world and test their skills in a competitive setting,” says Millie Lozada, a member of the GSK Corporate Executive Team.
“We chose Team Entercorp as the winner because their plan really showed their understanding of the business case we gave them. They demonstrated in-depth analysis and stayed focus on the objectives. This allowed them to identify a range of possible actions for the problem presented and came up with creative solutions to address them,” she explains.
Assuming the post of Commercial, Human Resources or Finance Director, students were grouped in corporations and participated in an elimination round where they were required to submit a written situation-target-proposal report on a business case. Two teams were then chosen to advance to the final Board Room Simulation. In the finals, both teams were given a general situation and key issues faced in the next business year and were tasked to form an integrated 5 year plan that touched on all functional areas.
Their strategy was then presented to members of GSK’s Corporate Executive Team, which included Finance Vice President Jude Braganza, Human Resources Vice President Lito De Guzman, Commercial Excellence Vice President Daisy Cembrano, Commercial Vaccines Vice President Millie Lozada and Legal and External Affairs Director Mailyn Ocampo.
“We were really impressed with the talents we got this year,” says Mr. Lito De Guzman. “Through this program, GSK was not only able to offer promising students the chance to experience working in the corporate world, it also helped us interface with who we feel are up and coming corporate leaders, people the company will want to watch out for in the future.”
GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

Back to top
We are the only pharmaceutical company to tackle the three "priority" diseases identified by the World Health Organization: HIV/AIDS, tuberculosis and malaria
Our business employs over 100,000 people in 117 countries
We make almost four billion packs of medicines and healthcare products every year
We screen about 65 million compounds every year in our search for new medicines
We supply one quarter of the world's vaccines and by the end of 2007 we had 23 vaccines in clinical development
To date, we have donated over 750 million albendazole tablets to help elimitate lymphatic filariasis (elephantiasis) in the world
In 2006 we shipped 126 million tablets of preferentially-priced Combivir and Epivir (our HIV treatments) to developing countries
Almost 100 countries benefitted from our humanitarian product donations